1/1
2 files

Patient-Reported Outcomes From a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

media
posted on 05.03.2021, 17:03 by Anca D. Askanase, George J. Wan, Mary P. Panaccio, Enxu Zhao, Julie Zhu, Roman Bilyk, Richard A. Furie

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History